EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in DTP3 Vaccination in Asia (2012–2023)

Ines Aguinaga-Ontoso iD, Laura Guillen-Aguinaga, Sara Guillen-Aguinaga iD, Rosa Alas-Brun iD, Miriam Guillen-Aguinaga, Enrique Aguinaga-Ontoso iD, Luc Onambele, Francisco Guillen-Grima iD

Vaccines · 19.08.2025 · 13 (8) · 877

DOI: 10.3390/vaccines13080877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 19.08.2025. Verfasst von Ines Aguinaga-Ontoso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Public University of Navarra, 31008 Pamplona, Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: DTP3 (diphtheria–tetanus–pertussis vaccine, third dose) coverage is a key indicator of the strength and continuity of routine immunization programs, which demonstrably reduces the burden of infectious diseases globally. This study aims to assess trends in DTP3 vaccination coverage across Asian regions and countries from 2012 to 2023, focusing on changes associated with the COVID-19 pandemic.

Methods

DTP3 vaccination data were obtained from official WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and analyzed using Joinpoint regression to detect statistically significant changes in vaccination trends. Data were grouped by five Asian subregions based on the UN geoscheme (Central, Eastern, Southeastern, Southern, and Western Asia), and trends were weighted using birth cohort sizes. The presence of joinpoints and annual percentage changes (APCs) was calculated, and potential pandemic-related disruptions were contextualized.

Results

At the continental level, Asia experienced a modest 0.4% annual increase in DTP3 coverage between 2012 and 2023, with a significant joinpoint detected in 2018. Following this, Southeast Asia’s coverage declined at an annual rate of −4.32% before beginning to recover in 2021, while South Asia showed a similar pattern. Country-level analysis revealed significant heterogeneity, with a comparison between 2019 and 2023 showing profound post-pandemic declines in some nations, such as Lebanon (–21%) and Myanmar (–9.4%), while others, like Iraq and the Philippines, achieved substantial recoveries with coverage increasing by over 6 percentage points. These trends contrasted with persistent declines in fragile states (e.g., Afghanistan, Yemen) and sustained high coverage in others (e.g., Bangladesh, Israel). The pandemic, systemic weaknesses, emerging vaccine hesitancy, and misinformation were identified as key influences.

Conclusions

There is progress in DTP3 coverage across Asia. There were pandemic-related disruptions, particularly in regions with fragile health systems. Strategies to address zero-dose and dropout children, improve service continuity, and counter misinformation are essential to meet immunization targets under the Immunization Agenda 2030.

Schlagwörter

Stichwörter der Autor:innen

AsiaCOVID-19 pandemicDTP3 vaccinationchild healthglobal health equityimmunization coveragejoinpoint regressionroutine immunizationvaccine hesitancyzero-dose children

Autor:innen und Institutionen

  • Department of Health Sciences, Public University of Navarra, 31008 Pamplona, Spain.
  • Group of Clinical Epidemiology, Area of Epidemiology and Public Health, Healthcare Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.
  • CIBER in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 46980 Madrid, Spain.
  • Department of Nursing, Kystad Helse-og Velferdssenter, 7026 Trondheim, Norway.
  • Department of Nursing, Clinica Universidad de Navarra, 28027 Madrid, Spain.
  • Peralta Health Care Center, Navarra Health Service, 31350 Peralta, Spain.

ORCID-Profile: Ines Aguinaga-Ontoso, Sara Guillen-Aguinaga, Rosa Alas-Brun, Enrique Aguinaga-Ontoso, Francisco Guillen-Grima

Zitieren

APA

Aguinaga-Ontoso, I., Guillen-Aguinaga, L., Guillen-Aguinaga, S., Alas-Brun, R., Guillen-Aguinaga, M., Aguinaga-Ontoso, E., Onambele, L., & Guillen-Grima, F. (2025). Trends in DTP3 Vaccination in Asia (2012–2023). Vaccines, 13(8), 877. https://doi.org/10.3390/vaccines13080877

Vancouver

Aguinaga-Ontoso I, Guillen-Aguinaga L, Guillen-Aguinaga S, Alas-Brun R, Guillen-Aguinaga M, Aguinaga-Ontoso E, et al. Trends in DTP3 Vaccination in Asia (2012–2023). Vaccines. 2025;13(8):877. doi:10.3390/vaccines13080877

BibTeX
@article{AguinagaOntoso2025,
  author = {Aguinaga-Ontoso, Ines and Guillen-Aguinaga, Laura and Guillen-Aguinaga, Sara and Alas-Brun, Rosa and Guillen-Aguinaga, Miriam and Aguinaga-Ontoso, Enrique and Onambele, Luc and Guillen-Grima, Francisco},
  title = {Trends in DTP3 Vaccination in Asia (2012–2023)},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {8},
  pages = {877},
  doi = {10.3390/vaccines13080877}
}
Kostenlos starten →